iCANDOC Precision Cancer Medicine doctoral education pilot invites applications for a part-time (50%) senior researcher position to operate in the directoral / managerial duties in the pilot.
The iCANDOC pilot aims to train 122 doctoral researchers at the University of Helsinki (UH) in Precision Cancer Medicine during 2024-2027 with a total budget of 31 M€. We are currently seeking an applicant to operate in directorial/managerial duties for the iCANDOC Precision Cancer Medicine doctoral education pilot.
The applicant ensures this exceptional pilot project reaches its goals. The applicant works as a member of the iCANDOC community of doctoral researchers, supervisors, and post-doctoral researchers and collaborates closely with the participating faculties/units, doctoral programs and the UH Doctoral School.
Task Description
The iCANDOC applicant is responsible for execution of the iCANDOC doctoral pilot at UH during 2024-2027 according to UH guidelines, UH Doctoral Pilot Board decisions, and iCANDOC UH Steering Board decisions and in collaboration with the UH Doctoral School, doctoral programs, and participating faculties/units. To this end the applicant acts as the presenter of matters for the iCANDOC UH Steering Board, which decides on iCANDOC-UH principles including use of funding among several units; alignment of practices at different faculties and doctoral programs and nomination of iCANDOC staff and working group. The appilicant also interacts actively with the iCANDOC and iCAN flagship community to facilitate organization of courses, seminars, and meetings in Precision Cancer Medicine as well as secondment opportunities among potential future employees. The applicant together with the iCANDOC staff identifies and attempts to resolve any barriers to the execution of iCANDOC. The University of Helsinki is the coordinating university for the national iCANDOC pilot and therefore the applicant is also in charge of organizing meetings of the National iCANDOC Steering Group with representatives from all 14 participating organizations. The applicant supervises the iCANDOC staff including a coordinator, a scientific coordinator and supported by the iCANDOC post-doctoral program participants. At the beginning tasks also involve helping in the selection processes of doctoral researchers and their onboarding.
The director is appointed by the Dean of the Faculty of Medicine based on agreement on the appointment in the iCANDOC Steering Board.
About You
Prerequisites for the position are a doctoral degree, evidence of scholarly research work, the teaching skills necessary for the position and the ability to manage a research group and obtain supplementary research funding. The optimal candidate is an active scientist in the iCANDOC area, and has demonstrated skills in executing large and complex projects. Good communication and collaboration skills and a detail-oriented and analytical approach to problem-solving are appreciated. Strong written and oral English skills are required, and Finnish skills are considered an advantage.
The part-time appointment (minimally 50%, negotiable) enables carrying out independent research in the iCANDOC area. The appointment will be on a fixed-term basis until the end of 2027. The salary will be based on level OPT 6-7 of the demands level chart for research and teaching personnel in the salary system of Finnish universities. A six-month trial period will be applied.
The University of Helsinki offers comprehensive services to its employees, including occupational health care and health insurance, unemployment and pension fund, a generous holiday package, sports facilities, and opportunities for professional development.
How To Apply
Please submit your cover letter and CV as A SINGLE PDF FILE in English using the University of Helsinki Recruitment System.
The University of Helsinki welcomes applicants from a variety of genders, linguistic and cultural backgrounds.
The closing date for applications is October 17, 2024 at 23:59 EEST.
Further information about the position can be obtained from officiating iCANDOC director, professor Tomi Mäkelä, +358-50-5286128, icandoc-info@helsinki.fi. For information on the recruitment process, please contact HR Specialist Anna Leppäkoski, anna.leppakoski(at)helsinki.fi.
Recruitment system support: rekrytointi(at)helsinki.fi
The University of Helsinki (https://www.helsinki.fi/en ) is an international scientific community of 40,000 students and researchers. It is one of the leading multidisciplinary research universities in Europe.
iCANDOC is a national doctoral education pilot in the area of the Research Council of Finland’s flagship project, iCAN – Digital Precision Cancer Medicine. It is funded as part of the Ministry of Education and Culture’s doctoral education pilot for 2024-2027. The goal is to develop and test a new, flexible program for 3-4 year doctorates by enhancing supervision practices and initiating doctoral studies already during an MD/Master’s program. Furthermore, the pilot aims to increase the mobility of trainees among partners and smoothen transitions to multiple career tracks.
Oncology Research at Orion is seeking an innovative, talented, and highly motivated team leader to guide a team of researchers and assistants working to identify, validate, and mechanistically characterize novel oncology targets, as well as to support preclinical drug discovery efforts to develop life-changing therapies.
About The Position
As the Head of Cancer Genomics, you will lead a team focused on identifying novel cancer vulnerabilities using genetic and molecular data. You will leverage innovative in vitro and in vivo model systems, along with a broad range of functional technologies such as CRISPR, RNAi, and small molecule approaches. This role is ideal for someone who enjoys the translational aspects of converting biology discoveries in cancer research into drug discovery programs and thrives in a team environment. Key Responsibilities include the following:
Lead a team of assistants and PhD and non-PhD level scientists providing scientific and technical guidance.
Develop and execute strategies for target identification, prioritisation, and validation. Apply genetic, biochemical, and cell biology techniques for detailed mechanistic studies of identified targets.
Lead the setup and execution of relevant assays and models for in vitro and in vivo screening and efficacy studies.
Drive the innovation and implementation of new techniques and methodologies to advance research projects.
Develop action plans, strategies, and go/no-go criteria at each stage of the drug discovery process.
Interact with internal and external experts, academic groups, and CROs to establish collaborations and support research projects.
Ensure delivery of a robust pipeline of high-value, high-confidence research projects
You will be based in Turku, Finland, and report to the Director of Oncology Research.
Description Of Unit
Orion’s pharmaceutical innovations are created within its R&D organisation. The organisation employs top professionals in the field of drug discovery and development.
There are around 400 professionals working in R&D. Orion R&D has offices in Espoo, Turku and Kuopio in Finland, and in Nottingham in England and in New York, NY, USA.
Cancer Genomics is one of three scientific units in Oncology Research, a part of Orion’s R&D Organization. Cancer Genomics Team is focused on the discovery of therapeutic targets and the development of life-changing therapies to build well-being of patients globally.
We Offer
Opportunity to work with a dynamic team of experts building up Oncology Research at Orion.
A highly interesting R&D pipeline and enthusiastic working environment with opportunities to use your own strengths to build your competence and career.
Exciting opportunity to innovate and have an impact on future therapies for patients.
An excellent working atmosphere based on the appreciation of colleagues, continuous development, and mutual trust. Learn more about Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/.
Requirements
A doctoral degree in Cell Biology, Molecular Biology, Biochemistry, or a related field with more than six years of post-doctoral experience in oncology research.
Deep understanding of the mechanisms driving cancer growth, synthetic lethal strategies, and experience in using genomic information and functional genomics data for identifying novel cancer dependencies, along with the integration and utilisation of large-scale multi-omic datasets.
Proficiency in a broad range of biochemical, molecular, and cell biological techniques, including
Expertise in in vitro and in vivo cancer models and cell proliferation assays.
Functional genomic techniques, such as RNAi and CRISPR.
Cell-based assays, including immunofluorescence and high content imaging.
In vitro high-throughput biochemical screening assays using recombinant proteins.
Good leadership and team management skills and demonstrated ability to drive projects to successful completion.
Candidates with experience in the pharmaceutical or biotechnology industry will be given preference.
Additional Information
If you are the person we are looking for, please submit your cover letter and CV via the link by 27th October 2024.
For more information on the Head of Cancer Genomics position, please contact Anu Moilanen, Director Oncology Research, tel. +358 50 966 7827 the following times: October 22nd, 16-17:00 EEST or Oct 24th 10-11 EEST.
Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person. Orion Corporation operates in more than 30 countries, where we Orionees, 3600 in total, work in all kinds of positions. Among us there are Research Scientists, Laboratory Technicians, Engineers and IT Specialists as well as people working in Production, just to mention some examples. We offer diverse and responsible jobs to our personnel in a truly multi-disciplinary work environment. We encourage people to develop their competences and offer opportunities to affect the job description and creating their own career path at Orion. We are searching for top talents who are ready to share our passion for the work that we do.
Aalto University is a community of bold thinkers where science and art meet technology and business. We are committed to identifying and solving grand societal challenges and building an innovative future. Aalto has six schools with nearly 11 000 students and a staff of more than 4000, of which 400 are professors. Our main campus is located in Espoo, Finland. Diversity is part of who we are, and we actively work to ensure our community’s diversity and inclusiveness in the future as well. This is why we warmly encourage qualified candidates from all backgrounds to join our community.
Two Doctoral Researchers in Super-Resolution Microscopy and Single Molecule Tracking
The project will investigate the biophysical mechanisms of cellular adaptation to environmental stresses and developing new methods to quantify and understand single molecule dynamics.
Many microorganisms can withstand severe environmental stresses, e.g. extreme temperatures, while maintaining cellular homeostasis and sub-cellular organization. To study this, we use state-of-the-art super-resolution microscopy and single molecule tracking to record the movement of individual molecules inside individual live cells. Single molecule dynamics reports on the molecular interactions in real-time, acting as a probe for changes in the cellular environment. The obtained knowledge will help us to understand microorganisms’ adaptation to different environments and the limits of cellular life. The research will also contribute to the development of synthetic biology applications and novel assay solutions.
Your role and goals We are looking for an enthusiastic and motivated doctoral researchers who are interested in applying and/or analyzing data from super-resolution microscopy and single particle tracking to study intracellular life of bacteria. You will contribute to some of the following areas: experimental work in the laboratory, imaging using a custom TIRF microscope, data analysis, machine learning, and modelling. You will adapt existing and develop novel methods and protocols to collect and analyse scientific data from a variety of sources so that hypotheses can be tested, reviewed and refined. You will also carry out collaborative projects with colleagues within our group and from other institutions. You are proactive, self-directed researcher who manages your projects effectively and presents the results at internal and external meetings and seminars.
You will work full time on the doctoral research and to complete the thesis and the associated studies in four years. The doctoral degree consists of the student’s research project resulting in peer-reviewed publications, studies specific to the research field, as well as transferable skills training.
Your network and team The Department of Neuroscience and Biomedical Engineering (NBE) aims to understand system-level dynamic functions of the human brain, mind, and body. We develop spearheading technology and computational methods which pave the way for discoveries and breakthroughs that contribute to health and wellbeing. NBE brings together systems and cognitive neuroscience, biophysics, and biomedical engineering. The levels of description in the research and education at the department range from molecular and cellular measures to noninvasive neuroimaging and behavioral measurements. New generations of multidisciplinary scientists and engineers are educated by engaging them with cutting-edge science and technology.
Your supervisor will be Assistant Prof. Jarno Mäkelä who is the head of the Single-Molecule Dynamics in Cells group. He has assembled a multidisciplinary team of experts in microbiology, biochemistry, microscopy, biophysics, and computer science, providing a collaborative environment for researchers to gain hands-on experience in cutting-edge microscopy, experimental lab work, data analysis and modelling. The team works on multiple topics at the interface of physics, chemistry, and biology: intracellular spatial organization, macromolecular crowding, liquid-liquid phase separation, heat- and cold-shock protein dynamics, and proteomics. You will be embedded in a highly supportive and stimulating research environment, where you will have the opportunity to receive excellent academic training and develop key skills for the future as an independent researcher.
Your experience and ambitions
MSc in biophysics, biotechnology, computational biology, or other relevant fields
Solid understanding of biology
Experience with at least one of the following is expected: fluorescence microscopy, signal processing, image analysis, machine learning or mathematical modelling
Coding skills (Python/Matlab or similar) to process and analyze experimental data
Ability and interest to work results-oriented in an interdisciplinary team
High self-motivation and persistence in tackling challenging scientific problems
Good written and oral communication skills in English (Finnish language is not required).
The Doctoral researcher applicants must fulfill the admission requirements for the Aalto Doctoral Programme in Science. Selected candidate is expected to apply for and to be granted a right to pursue doctoral studies at Aalto University. More information on the general requirements and the Doctoral Programme in Science https://www.aalto.fi/en/study-options/aalto-doctoral-programme-in-science-0 Please check the student information, admission criteria and pay attention to the required (English) language proficiency.
What we offer We offer you an interesting job in an inspiring work environment. You will be able to work in a community where we promote personal growth, collaborative atmosphere, transparency in communication. We will familiarize you with your tasks and you will be part of a friendly and competent team that will provide you with support for your work tasks, also in the future.
The total duration of Ph.D. studies is four (4) years. Following the standard Aalto’s practice the Doctoral reserarcher position contract will be made initially for two years, then extended to another two years after a successful mid-term progress review.
Aalto University follows the salary system of Finnish universities. The starting salary of the selected doctoral resercaher in this project is approximately 2746 EUR/month (gross), and it will increase with achievements, such as scientific publications.
The position will be full time and the annual workload of research and teaching staff at Aalto University is 1612 hours. The contract includes Aalto University occupational healthcare. We value work-life balance and the well-being of all team members.
In addition, Aalto University offers a vast array of professional development opportunities, which means you will grow and learn, having the chance to participate actively in staff trainings and development projects based on your interests and needs.
The primary workplace is Otaniemi campus at Espoo, Finland, which is a thriving and connected community of 100 nationalities, 13,000 students and 4,500 employees. Life at the transformed campus is vibrant and filled with amazing architecture, calming nature, and a variety of cafes, restaurants, services and good connections.
Ready to apply? To apply, please submit the following application materials in English (PDF files) through our recruitment site (”Apply now!”)
Letter of motivation (clearly describe of your research interests, how you would contribute to the project, and how you fulfill the above-listed requirements)
CV (max 2 pages) including a list of publications
Study transcript provided by the applicant’s university that lists studies completed and grades achieved
Degree certificates
Contact details of at least two referees
The deadline for applications is 31 October 2024 (Finnish time, UTC +2h ).
Please note: Aalto University’s employees should apply for the position via our internal HR system Workday (Internal Jobs) by using their existing Workday user account (not via the external webpage for open positions). Aalto University’s students and visitors should apply as external candidates with personal (not aalto) email.
The position will be filled as soon as a suitable candidate is identified.
For additional information, kindly contact Prof Jarno Mäkelä (jarno.p.makela@ aalto.fi). Recruitment system related matters you may contact HR partner Jenni Ståhl jenni.stahl at aalto.fi.
Aalto University reserves the right for justified reasons to leave the position open, to extend the application period, reopen the application process, and to consider candidates who have not submitted applications during the application period.
We will go through applications, and we may invite suitable candidates to interview already during the application period. We aim to have a transparent and equal recruitment process, so feel free to ask us for feedback.
More about Aalto University: Aalto.fi twitter.com/aaltouniversity facebook.com/aaltouniversity instagram.com/aaltouniversity Aalto University has been awarded with HR Excellence in Research quality label in European Commission, guaranteeing that we adhere to top quality HR practices in both recruitment and employment relations.
Our Customer Charles River Discovery is recruiting Manager / Senior Manager, Oncology to set up and lead their oncology research team in Kuopio, Finland.
Read from below how Charles River describes this interesting role.
For over 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
We are expanding our operations and therefore, we are now looking for a Manager / Senior Manager, Oncology to strengthen our drug development services. In this senior position, you will manage the planning and execution of our new therapy adaption project. You will be ensuring that all project related activities are performed in accordance with our policies, contractual agreements, quality standards, health and safety requirements, financial targets as well as schedule commitments.
This role requires both strong people leader experience and efficient establishment and project management skills. You master high-level design, management, and execution of multiple parallel projects to drive preclinical service program development. The position is permanent and full-time. Please note that this role requires your presence in Kuopio.
What you should bring with you:
MSc/PhD in Life Sciences or equivalent degree
Proven, vast track record of similar role(s) in the field of oncology and/or pharmacology
Clear and efficient communication skills in both English and Finnish
Strong attention to detail, ensuring accuracy and quality in deliverables
Capability to develop work practices and to take lessons learned and implement them into the processes
Ability to work under pressure to deliver the projects with time, cost, and quality
Analytical and problem-solving mindset, with the ability to identify and mitigate risks and challenges
Ability to adapt to changing priorities and work under tight deadlines and excellent collaboration and work multinational team
We offer you:
Working at Charles River means working in a dynamic international organization where we are making the difference. We offer you exciting projects, growth opportunities, meaningful work, inclusive and supportive team. We also support your wellbeing by offering you e.g., wide occupational healthcare, leisure accident insurance and ePassi flex- benefit. We also have an active recreational committee which organizes activities from charity occasions to fun team events.
Applications and more info:
Please send your application with CV by 20th October to our recruitment system. Please note that email applications are not taken into account.
Päivi Meltan (+358 50 351 8855) is the recruitment consultant taking care of this recruitment at Satafarma & Greige Oy and she is happy to give more information about the role. You will reach Päivi on 10th Oct 15.00- 17.00 or on 15th Oct 11.00-12.00
About Discovery Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
About Charles River Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 22,000 employees within 100 facilities in 26 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
Agilent inspires and supports discoveries that advance the quality of life. We provide life science, diagnostic and applied market laboratories worldwide with instruments, services, consumables, applications and expertise. Agilent enables customers to gain the answers and insights they seek –– so they can do what they do best: improve the world around us. Information about Agilent is available at www.agilent.com.
Do you have experience with technologies and applications in Genomics, Pathology and Cell Biology and are you looking to further develop your career? Then you might be the person we are looking for!
Agilent Technologies are currently looking for a driven and motivated team player to join as a HDX (Human Diagnostics) Market Specialist for Regions: Denmark/Sweden/ Norway/ Finland
As a Market Specialist , you will be a part of an European Team of Market Specialists, which is closely embedded into the European DGG sales structure. In this critical role, you will apply your expertise and knowledge of the DX market to work with healthcare diagnostic accounts, supporting the sales team in your region, doing Business Development by promoting new applications, uncovering emerging applications in the field of HDx, identifying new customer groups and closely interact with the Marketing and the Business Units of Agilent.
Your primary responsibilities are our suite of genomics and pathology products, instruments and software solutions for immunohistochemistry, molecular pathology and human genetics. Your goal is to proactively develop and implement a successful strategy together with your colleagues from the sales and support teams , to help the organization in exceeding quota and develop new opportunities and strategies for the coming years.
Specifically, this means:
Develop effective strategies and tactics to grow new business
Effectively prospect to find new opportunities in existing and new accounts
Leverage deep knowledge of strategic focus area to develop compelling value proposition
Recognize trends that impact buying of Agilent products
Provide front-line support to HDx Account Managers with persuasion activities
Partner with Account Managers to assist with seminars and negotiations
Qualifications
Bachelor or Master degree or University degree in Biology/Biochemistry/Chemistry (or related)
4+ years practical experience in a relevant environment
Excellent communication skills in Danish or Swedish and English (written and verbal)
You’ve established a proven track record and you are looking for new challenges in the health care diagnostic field to make a real difference and impact the field.
We offer:
A commitment to work/life balance
Total Compensation Package including company car and retirement programs.
Training and development opportunities
An enthusiastic team
A company with values around innovation and contribution, uncompromising integrity, trust, respect and teamwork, speed, focus, and accountability
The diversity of cultural and individual perspectives held by our employees and their commitment to inclusion
Should you have any questions regarding the application process, please contact the recruiter on Natalie.gesler@agilent.com
Agilent Technologies Inc. is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other protected categories under all applicable laws.
For over 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
IMPORTANT: In order to be considered for this position, a resume/CV must be uploaded and submitted during the application process. Please make sure work history and education are added correctly.
Join our team and make the difference!
We are expanding our operations and therefore, we are now looking for a Research Leader to strengthen our drug development services. In this senior position, you will manage the planning and execution of our new therapy adaption project. You will be ensuring that all project related activities are performed in accordance with our policies, contractual agreements, quality standards, health and safety requirements, financial targets as well as schedule commitments. This role requires both strong people leader experience and efficient establishment and project management skills. You master high-level design, management, and execution of multiple parallel projects to drive preclinical service program development. The position is permanent and full-time.
What You Should Bring With You
MSc/PhD in Life Sciences or equivalent degree
Proven, vast track record of similar role(s) in the field of oncology and/or pharmacology
Clear and efficient communication skills in both English and Finnish
Strong attention to detail, ensuring accuracy and quality in deliverables
Capability to develop work practices and to take lessons learned and implement them into the processes
Ability to work under pressure to deliver the projects with time, cost, and quality
Analytical and problem-solving mindset, with the ability to identify and mitigate risks and challenges
Ability to adapt to changing priorities and work under tight deadlines and excellent collaboration and work multinational team
What We Offer You
Working at Charles River means working in a dynamic international organization where we are making the difference. We offer you exciting projects, growth opportunities, meaningful work, inclusive and supportive team. We also support your wellbeing by offering you e.g., wide occupational healthcare, leisure accident insurance and ePassi flex- benefit. We also have an active recreational committee which organizes activities from charity occasions to fun team events.
More info: Associate Director Laboratory Sciences, Tuulia Huhtala (+358504366373) available on Wednesday 11th of September between 15-16 and on Friday 27th of September between 9-10. (UTC+2)
Apply at the latest by 29th of September, we may start interviewing candidates already during the application period.
”When you approach each moment knowing your work helps improve the health and lives of millions worldwide – suddenly everything seems possible. At Charles River, this is the passion that drives us. Join us today and start imagining tomorrow.”
About Discovery
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles, and move us forward together on the journey of getting new drugs to market.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 22,000 employees within 100 facilities in 26 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of 86% of the drugs approved by the FDA in 2021.
For more information, please visit www.criver.com.
have you ever wondered how much career planning is really necessary? What career paths are possible within the life sciences and how do I have an impact?
Biobio Junior Section, supported by the 60-year anniversary of the Federation of European Biochemical Societies (FEBS), has organised a panel discussion around these questions.
Suvi Haimi, Co-founder of Sulapac and Emma Raitoharju, Academy Research Fellow at Tampere University will talk about their careers in the first panel.
In the second panel, Irene Diaz-Moreno, Chair of the FEBS Career Young Scientists Committee and Professor at the University of Seville and Mario Brandenburg, Parliamentary State Secretary to the Federal Minister of Education and Research, will provide their insights into how organizations such as FEBS can shape one’s career and how scientists can work together with politics to implement policies.
We are happy to tell that the Finnish society for Cell biology will arrange the SSB Life Science Business & Innovation Seminar, held for the very first time in Tampere! Join us on November 14th, 2024 at Tampere University (room F114) for an afternoon of learning about entrepreneurship in life sciences, networking, and great company.
What to expect?
Learn about entrepreneurship in life science sector
Meet local and near-by companies
Enjoy snacks and drinks during a relaxed networking session
The seminar starts at 14:00, and for those unable to attend in person, the event will be streamed via Zoom! Registration is required for both in-person and virtual attendance.
Coffee will be served during the seminar! Also, all attendees physically present who also join the society will have a chance to participate in an exciting raffle with a Finnkino gift card as the prize! Additionally, all our society members will receive our brand-new overall patch!
Speakers include:
Helena Lähdekorpi, Tampere University
Prof. Jari Hyttinen, BioMediTech
Jarno Tanskanen, OrganAnalytics
Tomi Saviluoto, UPM Biomedicals
Olli Pitkänen, PrecisionPhage Ltd
Jenni Karttunen, Tampere Imaging Facility
Elina Mäntylä, Euro-BioImaging
Thomas Liuksiala, Genevia Technologies
Laura Koivusalo, StemSight Oy
Varpu Marjomäki, Natural Antivirals
Important information regarding the seminar room! We will start the seminar as planned in room F114. For the coffee break, we will move to the Yellow room (Keltainen sali) F025, where the remainder of the event will also take place. See the program!
Whether you’re a student, researcher, or working professional, this event is for you! Register now and secure your spot (DL for on-site registration on 10.11., and for Zoom participation 12.11.): https://link.webropolsurveys.com/EP/6D54C63E274886A8
The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a
Doctoral Researcher
to the education pilot in precision cancer medicine (iCANDOC)to join our Breast Cancer Genetics team inBiocenter Ouluand Translational Medicine Research Unit, Faculty of Medicine, at the University of Oulu.TheFaculty of Medicine, an integral part of the Kontinkangas Life Sciences Campus, is situated next to the University Hospital of Oulu. The campus is a unique combination of partners in research, education, health services and business.
About the job
A Doctoral Researcher position is available in the Breast Cancer Genetics teamlead by Professor Katri Pylkäs. The team aims to elucidate genetic risk factors for breast cancer, and to resolve the molecular mechanisms leading to breast cancer predisposition and subsequent malignant conversion. In this Doctoral Researcher project the focus is on deciphering genetic landscape of breast tumors through optical genome mapping and exome sequencing.The research will be conducted at the Translational Medicine Research Unit, Faculty of Medicine, and Biocenter Oulu. We have excellent molecular biology laboratories and instrumentation concerning the project’s needs. The Doctoral Researcher will join the University of Oulu Graduate School (UniOGS), which provides the framework and conditions for high-quality, research-driven doctoral training.
What we offer?
An exiting research project utilizing the state-of-the art genomic methods
The support of an experienced and enthusiastic research team where you can share your expertise and grow as an expert.
We have a HR Excellence in Research -quality label which is a recognition awarded by the European Commission for the development of researchers’ working conditions and careers.
Finland is one of the most livable countries in the world, with a high quality of life, safety, excellent education system, and competitive economy. Read more about living in Oulu.
Who are you?
You are the person we are looking for if you have:
Master’s degree in genetics, molecular genetics or bioinformatics or equivalent (the degree needs be completed before the starting date)
High motivation and the ability to work efficiently both independently and as part of a team
Solid background knowledge in genetics and genomics
Experience in conducting molecular geneticslaboratory work
Previous experience in genomic data analysis (exome-sequencing and/or optical genome mapping) is considered an advantage
Salary
Doctoral researchers selected in the pilot programme will by default be offered a three-year (36 month) fixed-term full-time employment contract by University of Oulu. These positions are available for highly motivated and talented researchers wishing to undertake and complete training for a research-focused doctoral degree, starting 1.1.2025 at the earliest. The selected applicants are expected to start their project no later than 1.2.2025. A six-month trial period is applied in the position.
The salary of the selected doctoral researchers will be paid monthly. The salary will be based on the levels 2-4 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 2500-2800 € per month (before taxes).
How to apply?
Applications, together with all relevant enclosures, should be submitted using the electronic application form by 15.10.2024 (23:59 Finnish local time). The application should be written in English and include the following:
A motivation letter (max. 2 pages) summarizing applicant’s professional experience and expertise and describing why the applicant is a good fit for this position. Also, information on personal research interests, experience and career plans are valuable to provide here.
Curriculum vitae (max. 2 pages). A recommended CV template can be found on the Finnish National Board on Research Integrity.
Certificates/Diplomas Scanned copy of the original relevant master’s degree certificates and transcript of records and, when necessary, official translations to Finnish or English.
Only applications containing all relevant appendices and submitted through the online recruitment system will be considered. Applications received after the call deadline will not be considered.
We welcome applicants from all backgrounds, including people of different ages, genders, and linguistic, cultural, or minority groups.
Contact Information
For further information, please contact Professor Katri Pylkäs (katri.pylkas(at)oulu.fi)
The University of Oulu is a multidisciplinary, international research university, with about 3,600 employees who produce new knowledge based on high-standards research and provide research based education to build a more sustainable, smarter, and more humane world. The University of Oulu community has about 17,000 people in total. Our northern scientific community operates globally and creates conditions for the emergence of innovations.
We are now looking for a
Doctoral Researcher
to the education pilot in precision cancer medicine (iCANDOC)to join our Colorectal Cancer Research Group in Translational Medicine Research Unit at the Faculty of Medicine of University of Oulu.
The Faculty of Medicine, an integral part of the Kontinkangas Life Sciences Campus, is situated next to Oulu University Hospital and is a unique combination of partners in research, education, health services, and business.
About the job
Colorectal cancer, the third most common cancer, is a highly heterogeneous disease at both molecular and morphological levels. Its progression is shaped by complex interactions between tumor cells and the surrounding stromal and immune cells. Our research group focuses on three key areas: (1) identifying the factors that drive colorectal cancer heterogeneity, (2) uncovering the role of tumor-host interactions in disease progression, and (3) developing novel biomarkers to advance precision medicine.
As a doctoral researcher in our group, you will participate in the analysis of large colorectal cancer cohorts. You will apply techniques such as multiplex immunohistochemistry, in situ hybridization, spatial transcriptomics to uncover the molecular variations that drive tumor phenotypes in colorectal cancer. You will apply data analysis methods and bioinformatics analyses to analyze large-scale molecular data. The findings of the project could refine future tumor classification systems, aid in developing novel biomarkers, and enable more personalized treatment approaches.
The doctoral training will give you a strong background for future tissue-based research related to cancer biology, tumor immunology, and bioinformatics. It will offer rich opportunities for networking, mobility, and further career development after completing the PhD in three years.
What we offer?
The support of an experienced and enthusiastic research team.
A dynamic research environment which promotes personal and professional growth as a scientist.
Possibility to gain expertise in cutting-edge tissue analysis methods such as multiplex immunohistochemistry and in situ hybridization, as well as sequencing-based molecular pathological methods.
We have a HR Excellence in Research -quality label which is a recognition awarded by the European Commission for the development of researchers’ working conditions and careers.
Finland is one of the most livable countries in the world, with a high quality of life, safety, excellent education system, and competitive economy. Read more about living in Oulu.
Who are you?
In order to succeed and enjoy the position, we expect from you:
Master’s or equivalent degree (e.g. licentiate) in biochemistry, biomedicine, bioinformatics, cell biology, data analysis, genetics, medicine, molecular biology, molecular genetics, or related fields
Strong motivation to learn and apply new research methods relevant to the project
Excellent communication and teamwork skills
Fluent in written and spoken English
We also appreciate
Previous experience in bioinformatics analyses and/or tissue/molecular analysis methods is considered an advantage
Doctoral researchers selected in the pilot programme will by default be offered a three-year (36 month) fixed-term full-time employment contract by University of Oulu. These positions are available for highly motivated and talented researchers wishing to undertake and complete training for a research-focused doctoral degree, starting January 1, 2025 at the earliest. The selected applicants are expected to start their project no later than February 1, 2025. A six-month trial period is applied in the position.
The salary will be based on the levels 2-4 of the demand level chart for teaching and research staff of Finnish universities. In addition, a salary component based on personal work performance will be paid (maximum of 50 % of the job-specific component). Starting gross salary will be approx. 2500-2800 € per month (before taxes).
How to apply?
Interested? If yes, please apply by 23.10.2024 (23:59 Finnish local time) through our recruitment system.
The application should be written in English and include the following:
A motivation letter (max. 2 pages) summarizing your professional experience and expertise and describing why you are a good fit for this position. Also, information on personal research interests, experience and career plans are valuable to provide here.
Certificates/Diplomas Scanned copy of the original relevant master’s degree certificates and transcript of records and, when necessary, official translations to Finnish or English.
Only applications containing all relevant appendices and submitted through the online recruitment system will be considered. Applications received after the call deadline will not be considered.
We welcome applicants from all backgrounds, such as people of different ages, genders and lingual, cultural or minority groups.
Contact Information
If you have any further questions, please contact Juha Väyrynen (juha.vayrynen(at)oulu.fi).
